Compatibilità
Salva(0)
< BACK TO NEWS
March 25, 2026
53Biologics has announced the closing of a strategic funding round led by REN Life Sciences, with participation from existing investors including Inveready. The transaction will support the company’s expansion in GMP biomanufacturing and strengthen its position as a key player in Europe’s biologics manufacturing infrastructure.
blanca
